IDEAYA Biosciences Inc at Jefferies Healthcare Conference Transcript
My name is Maury Raycroft, and I'm one of the BioTech analysts at Jefferies. And it is with great pleasure that I'd like to welcome the CEO of IDEAYA, Yujiro Hara and the CMO, Darrin Beaupre. They are both joining us today for a fireside chat discussion. Thanks so much for joining us.
Great. Thank you, Maury, for the kind introduction and thank you to Jefferies for the opportunity to participate this year at your event.
And maybe for those who are new to the story, you can give a 1-minute intro to IDEAYA.
Sure. So IDEAYA was founded 7.5 years ago. We're a leading precision medicine oncology, biotechnology company. Today, we have three first-in-class clinical programs. The first is darovasetib. Here, this is specifically targeting a genetic alteration called GNAQ/GNA11. The lead
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
